Relevance and safety of telomerase for human tissue engineering.
Ontology highlight
ABSTRACT: Tissue engineering holds the promise of replacing damaged or diseased tissues and organs. The use of autologous donor cells is often not feasible because of the limited replicative lifespan of cells, particularly those derived from elderly patients. Proliferative arrest can be overcome by the ectopic expression of telomerase via human telomerase reverse transcriptase (hTERT) gene transfection. To study the efficacy and safety of this potentially valuable technology, we used differentiated vascular smooth muscle cells (SMC) and vascular tissue engineering as a model system. Although we previously demonstrated that vessels engineered with telomerase-expressing SMC had improved mechanics over those grown with control cells, it is critical to assess the phenotypic impact of telomerase expressi
SUBMITTER: Klinger RY
PROVIDER: S-EPMC1413782 | biostudies-literature | 2006 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA